BCAX Bicara Bio: Bozor kapitallashuvining balans qiymatiga nisbati
GURU.Markets platformasida Bicara Therapeutics Inc. (BCAX) aksiyalarining narx dinamikasi kichikroq raqobatchilarga qarshi ustunligi bifunksional antitanachlar patentlari va ulkan R&D xarajatlari bilan ta'minlangan biznesni aks ettiradi. Kompaniya hozirda naqd pullarni sarflash bosqichida bo'lib, IPOdan tushgan mablag'larni bosh va bo'yin saratoni terapiyalarini o'rganishga yo'naltirmoqda, bu yerda ko'rsatkich 1.37 darajasida turibdi. Moliyaviy poydevor jalb qilingan kapitalga tayanadi, kelajakdagi pul oqimi esa klinik sinovlarning natijalariga bog'liq.
%20-%20Kapitallashuvning%20sof%20aktivlarga%20nisbati&width=1200&height=400&colorIndex=0&v=mvt4kixj.9g-7avve2o&start=20220704&end=20261029&filename=GURU_Markets_-_BCAX_-_Bicara-Therapeutics-Inc._-_Market-Cap-to-Net-Assets-Ratio "BCAX Bicara Bio Bozor kapitallashuvining balans qiymatiga nisbati (14.11.2024 - 29.10.2026) | 👁️GURU.Markets👁️")
BCAX (Bicara Therapeutics Inc): tahliliy kesimlar va indikatorlar boʻyicha maʼlumotlar
- narx va narxlar bo'yicha konsensus prognoz:
- bozor kapitallashuvi bo'yicha ma'lumotlar:
- balans kapitallashuvi bo'yicha ma'lumotlar:
- qarz va likvidlik bo'yicha ma'lumotlar:
Umumiy qarzning kapitalga nisbati Bicara Therapeutics Inc.|BCAX - Uzoq muddatli qarzning o'z kapitaliga nisbati|Qisqa muddatli qarzning kapitalga nisbati Bicara Bio|BCAX - Kompaniyaning umumiy yig'indi qarzi|Qarzning balans kapitallashuviga nisbati Bicara Bio|BCAX - Kompaniyaning uzoq muddatli kredit va qarzlari|Kompaniyaning qisqa muddatli majburiyatlari Bicara Therapeutics
Fundamental baholash:BCAX (Bicara Therapeutics Inc.)
Noaniqlik davrida kapitalni himoya qilish uchun investorlarga Bicara Therapeutics Inc. (BCAX) bozor qiymatini uning moddiy aktivlari bilan solishtirish zarurdir. Noyob Ficerafusp alfa antitelalarning ishlab chiqilishi fundamental bazani yaratadi, bu esa 1.37 qiymatidagi kitob qiymatiga nisbatan narx tarixida bozor kapitalizatsiyasining kapitalga nisbati sifatida aks etadi va biznesning kitob qiymatiga nisbatan haddan tashqari qimmat yoki arzon baholanganligini aniqlash imkonini beradi.
Asosiy raqobatchilar
Kapitallashuvning sof aktivlarga nisbati BeiGene Ltd|halozyme.com (HALO) - Kapitallashuvning balans qiymatiga nisbati|Bozor kapitallashuvining balans qiymatiga nisbati RVMD|Kapitallashuvning sof aktivlarga nisbati Ascentage Pharma Group International|Bozor kapitallashuvining balans qiymatiga nisbati CGON|Bozor kapitallashuvining balans qiymatiga nisbati URGN (UroGen Pharma Corp)|PSNL - Bozor qiymatining balans qiymatiga nisbati|Kapitallashuvning balans qiymatiga nisbati erasca.com ERAS|DCTH: Bozor kapitallashuvining balans qiymatiga nisbati|YMAB - Kapitallashuvning sof aktivlarga nisbati|Bozor kapitallashuvining balans qiymatiga nisbati AURA|CADL (Candel Therapeutics, Inc.) - Bozor qiymatining balans qiymatiga koeffitsiyenti|ARAY - Bozor qiymatining balans qiymatiga nisbati|Balans qiymatiga nisbatan bozor qiymati SELLAS Life Sciences Group Inc. (SLS)|Actuate Therapeutics (ACTU) - Kapitallashuvning sof aktivlarga nisbati|Balans qiymatiga nisbatan bozor qiymati Citius Oncology Inc. (CTOR)|TuHURA Biosciences - Bozor kapitallashuvining balans qiymatiga nisbati|TARA - Kapitallashuvning sof aktivlarga nisbati|Fate Therapeutics, Inc. - Kapitallashuvning sof aktivlarga nisbati|WHWK: Bozor kapitallashuvining balans qiymatiga nisbati|Bozor qiymatining balans qiymatiga nisbati tscan.com TCRX|Champions Oncology, Inc. (CSBR) - Balans qiymatiga nisbatan bozor qiymati|Bozor kapitallashuvining balans qiymatiga nisbati XBIT (XBiotech Inc)|Bozor qiymatining balans qiymatiga koeffitsiyenti CEL-SCI Corp|Bozor kapitallashuvining balans qiymatiga nisbati OS Therapies Incorporated (OSTX)|Bozor qiymatining balans qiymatiga nisbati Radiopharm Theranostics Ltd (RADX)|Bozor kapitallashuvining balans qiymatiga nisbati ARTV|Balans qiymatiga nisbatan bozor kapitallashuvi Adlai Nortye Ltd ANL|VERU: Bozor kapitallashuvining balans qiymatiga nisbati|TPST - Kapitallashuvning sof aktivlarga nisbati|XLO: Bozor kapitallashuvining balans qiymatiga nisbati|RENB (Renovaro) - Bozor kapitallashuvining balans qiymatiga nisbati|MURA - Bozor qiymatining balans qiymatiga nisbati|Balans qiymatiga nisbatan bozor qiymati Kairos Pharma Inc|Bozor kapitallashuvining balans qiymatiga nisbati OKUR|Bozor kapitallashuvining balans qiymatiga nisbati w2.cytomed.sg GDTC|Kapitallashuvning sof aktivlarga nisbati Curis|APLM - Balans qiymatiga nisbatan bozor qiymati|Kapitallashuvning sof aktivlarga nisbati Tharimmune THAR|ADVB - Bozor kapitallashuvining balans qiymatiga multiplikatori|Bozor kapitallashuvining balans qiymatiga nisbati Genprex, Inc GNPX|Calidi Biotherapeutics, Inc. (CLDI) - Balans qiymatiga nisbatan bozor qiymati|Bozor kapitallashuvining balans qiymatiga nisbati SBFM (Sunshine Biopharma)|Bozor qiymatining balans qiymatiga koeffitsiyenti XBIO|Salarius Pharmaceuticals, Inc. (SLRX) - Bozor qiymatining balans qiymatiga nisbati|Balans qiymatiga nisbatan bozor qiymati Purple Biotech Ltd (PPBT)|Bozor kapitallashuvining balans qiymatiga nisbati AONC (American Oncology Network, Inc.)|BeiGene Ltd - Bozor kapitallashuvining balans qiymatiga nisbati|Bozor qiymatining balans qiymatiga nisbati Checkpoint Therapeutics|ELEV - Sof aktivlarga nisbatan bozor kapitallashuvi|Bozor kapitallashuvining balans qiymatiga nisbati ICAD|Bozor qiymatining balans qiymatiga koeffitsiyenti Ikena Oncology|NTBL (Notable Labs Inc.) - Kapitallashuvning sof aktivlarga nisbati|Bozor kapitallashuvining balans qiymatiga nisbati Viracta (VIRX)|Kapitallashuvning sof aktivlarga nisbati MorphoSys AG|Bozor kapitallashuvining balans qiymatiga multiplikatori nayabiosciences.com (NAYA)|Bozor kapitallashuvining balans qiymatiga nisbati AAPGV